In contrast, the mOS of diffuse astrocytoma, MYB- or MYBL1-altered, was 46.3 months, suggesting that adult patients with high-grade pediatric-type diffuse glioma are less likely to experience longer survival and better prognosis. Here, MYBL1 is linked to diffuse astrocytoma.